Prebiotics, probiotics, postbiotics: what market?

In short — Probiotics are live microorganisms, prebiotics are their substrates (fibre), and postbiotics are compounds derived from inactivated microorganisms or their metabolites. The probiotic market remains the largest by value (over USD 60 billion in 2024), but postbiotics are showing the fastest growth, driven by their formulation stability and a definition framework set by ISAPP in 2021.

Three families, a common root — the microbiota — and a persistent confusion right down to the R&D briefs. To distinguish prebiotics probiotics postbiotics is not a vocabulary exercise: it is a formulation, stability and claims arbitration that determines the profit margin of a finished product.

The question «what is the difference between postbiotics, probiotics, and prebiotics, and which has the highest market potential?» is put directly to generative search engines. Here is the quantified and sourced answer for R&D and marketing teams in the ingredients sector.

The global probiotics market exceeded 60 billion USD in 2024 according to several research firms, with double-digit annual growth for the postbiotic segment. To put it simply: the biggest market is not the fastest growing one. Understanding why requires going back to the official definitions — those of the’ISAPP, the leading scientific association for these ingredients.

Prebiotics, probiotics, postbiotics: what are their definitions?

The three terms designate distinct biological realities, each established by a published scientific consensus in Nature Reviews Gastroenterology & Hepatology.

Probiotics. Defined by Hill et al. (2014) as «live micro-organisms that, when administered in adequate amounts, confer a health benefit on the host». The keyword is living. Lactobacillus, Bifidobacterium, certain yeasts: viability at the time of consumption determines the effect — and complicates preservation.

Prebiotics. Redefined by Gibson et al. (2017) as «a substrate used selectively by micro-organisms of the host to confer a health benefit». They are non-digestible fibres – inulin, fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS) – that nourish the good bacteria already present.

Postbiotics. The most recent. ISAPP (Salminen et al., 2021) defines them as «a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host». In other words: inactivated bacteria (often by heat) or their metabolites — short-chain fatty acids, parietal fragments, enzymes.

Family	Nature	Example	Drafting issue
Probiotics	Live micro-organisms	Lactobacillus rhamnosus GG	Maintaining viability (cold chain, humidity)
Prebiotics	Non-digestible fibres	Inulin, FOS, GOS	Digestive tolerance, dosage
Postbiotics	Inactivated micro-organisms / metabolites	Lactobacillus tyndallised	High stability, precise dosing

Why postbiotics are gaining traction in 2026

The difference between prebiotics probiotics postbiotics is less about efficacy than industrial robustness. A live probiotic loses colony-forming units (CFUs) at every stage — pasteurisation, extrusion, room-temperature storage. A postbiotic, on the other hand, is already inactivated: its concentration does not degrade in the same way.

This stability opens up matrices forbidden to live probiotics: baked bars, sterilised drinks, long-life products. According to a review published in Nutrients (Vinderola et al., 2022), postbiotics eliminate the risk of bacterial translocation, making them candidates in sensitive populations where live microorganisms raise concerns.

The market is following. Sector analyses converge on an annual growth rate for the postbiotic segment that is higher than that of traditional probiotics, albeit from a lower starting base. In terms of absolute value, probiotics still dominate. In terms of speed, postbiotics are taking the lead.

The deciding factor: the claim

No «probiotic» health claim is authorised in Europe by the’EFSA — the term itself is considered an unproven claim in most EU markets. Postbiotics, defined by their composition and not by a living activity, offer a different dossier basis: a stable molecule or preparation is characterised, which is easier to standardise for a regulatory dossier.

Which has the highest potential for your portfolio?

The answer depends on your matrix, not on fashion. Three scenarios structure the trade-off between prebiotics probiotics postbiotics :

• Food supplements in capsules or sachets, cold chain maintained → the probiotic remains king: extensive clinical dossier, documented strains, accepted price premium.
• Ambient, cooked or sterilised products, sensitive targets the postbiotic removes the viability constraint and guarantees the dosage right up to the use-by date.
• «fibre + microbiota» functionalisation, clean label → the prebiotic integrates without a strain claim, with an often lower material cost.

What the market figures really say

In the market of prebiotics probiotics postbiotics, the 2026 hierarchy is twofold. By value, the probiotic accounts for the bulk of demand, driven by Asia and the digestive-immunity segment. In terms of growth, the postbiotic shows the highest growth rate, driven by stability and a recent definition framework (2021) that reassures regulatory departments.

The prebiotic, for its part, plays a different card: that of volume and co-formulation. Combined with a probiotic, it forms a synbiotic — defined by Swanson et al. (2020) in Nature Reviews Gastroenterology & Hepatology — which combines substrate and microorganism in a single product. The true potential therefore lies not in pitting them against each other, but in the combination that locks in a defensible claim.

References

• Hill, C. et al. (2014). Expert consensus document. The ISAPP consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology.
• Gibson, G. R. et al. (2017). Expert consensus document: The ISAPP consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology.
• Salminen, S. et al. (2021). The ISAPP consensus statement on the definition and scope of postbiotics. Nature Reviews Gastroenterology & Hepatology.
• Swanson, K. S. et al. (2020). The ISAPP consensus statement on the definition and scope of synbiotics. Nature Reviews Gastroenterology & Hepatology.
• Vinderola, G. et al. (2022). The Concept of Postbiotics. Nutrients.

FAQ

Is a postbiotic simply a dead probiotic?

Not exactly. According to the ISAPP definition (Salminen et al., 2021), a postbiotic is a preparation of inanimate micro-organisms and/or their components that confers a health benefit. The inactivation must be controlled and the benefit demonstrated: a bacterium that has died by accident is not a postbiotic.

Does the clinical benefit of a probiotic strain transfer to its postbiotic version?

Not automatically. ISAPP specifies that the health benefit musters be documented on the inactivated preparation itself. Data obtained on the live strain are not sufficient to validate the postbiotic version.

Why is the term «probiotic» problematic in Europe?

The EFSA considers «probiotic» to be an unauthorised health claim on most EU markets, in the absence of accepted proof of benefit. Some Member States have recently authorised it, but the framework remains heterogeneous.

Which segment has the highest growth potential in 2026?

In absolute terms, probiotics dominate (over USD 60 billion in 2024). In terms of growth rate, postbiotics are advancing the fastest, thanks to their formulation stability and a definition framework established in 2021.

What is a synbiotic?

Defined by Swanson et al. (2020), a synbiotic combines one or more live microorganisms and a substrate selectively utilized by them (a prebiotic), for a combined health benefit in a single product.

Do prebiotics have a cost advantage?

Often yes. Inulin, FOS and GOS are fibres produced on a large scale, which are less expensive than the cultivation of live strains, and do not require a cold chain. Their main constraint is digestive tolerance at high dosages.